Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

2023
Clin Ther

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Clinical development

Affiliations

Department of Neuroscience, University of Padua, Padua, Italy. Department of Ophthalmology, Tours University Hospital, Université François Rabelais, Hôpital Bretonneau, Tours, France. Department of Ophthalmology, Hospital Clinico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria del Hospital Clinico San-Carlos (IdISSC), Madrid, Spain; Clínica Rementería, Madrid, Spain. Santen SAS, Évry-Courcouronnes, France. Department of Ophthalmology, Fondation A de Rothchild, Paris, France. University Hospital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; Rare Eye Disease Center (OPHTARA), Paris Cite University, Paris, France. Electronic address: dominique.bremond@aphp.fr.

Related Publications

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P, Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

Management of inflammation in dry eye disease: Recommendations from a European panel of experts

Messmer EM, Ahmad S, Benitez del Castillo JM, Mrukwa-Kominek E, Rolando M, Vitovska O, Baudouin C, On behalf of a panel of European Dry Eye Disease experts